RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate. Houston, TX and St. Louis, MO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that their investigational diagnostic radiopharmaceutical,...